Miscellaneous dermatological conditions:

Indications for ESKATA:

Raised seborrheic keratoses.

Adult Dosage:

For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.

Children Dosage:

Not applicable.

ESKATA Warnings/Precautions:

Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.

ESKATA Classification:

Oxidizing agent.

Adverse Reactions:

Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.

Generic Drug Availability:

NO

How Supplied:

Pen applicator (1.5mL, 2.2mL)—1, 3, 12